Subscribe

Advocacy News

Although the National Organization of Rheumatology Managers (NORM) is always here to be a strong voice for our members, your independent voice is just as important. People often feel that the efforts of a large group are more effective than the efforts of individuals when it comes to fighting for an issue, but the truth is that our state and federal representatives want and need to hear from you. In addition, insurance companies want to know just how many people are affected by a particular issue, such as a change in billing policy. These people and organizations need to understand why you, as an individual, feel that the fight is important.
Have you ever considered hosting a Walk to Cure Arthritis? It may be easier than you think. Andre C. Smith, CMPM, CPB, CRHC, discusses tips and tricks to help with the careful planning of your first annual walk!

New Hampshire Senate Bill 581 (SB581) was introduced into the New Hampshire Senate in January 2018. It amends the definition of “compounding” to preclude the preparation of a single dose of a nonhazardous, commercially available drug or licensed biologic for administration to an individual patient prepared in accordance with the manufacturer’s approved labeling.

ATAP strongly supports a mandatory pass-through, as it would directly benefit patients by reducing their costs at the pharmacy counter.

As of December 2017, 32 states and the District of Columbia have adopted USP 797 into law, including New Hampshire. Once adopted, a state agency, which is typically the state’s Board of Pharmacy, must be appointed to oversee and enforce these standards.


Results 1 - 5 of 5
  • American Health and Drug Benefits
  • Lynx CME
  • Value Based Care in Rheumatology
  • Oncology Practice Management
  • Urology Practice Management

Search